Clinical Presentation and Outcome of Infective Endocarditis: A Five-year Experience at Chaophya Abhaibhubejhr Hospital, A Provincial Community Hospital in Thailand

Main Article Content

Subencha Pinsai
Chawakorn Payackpunth
Wuttipat Keeratitadapong
Palida Phoungphol

Abstract

BACKGROUND: Infective endocarditis has a broad clinical manifestation with multi-organ involvement. Infective endocarditis is common in developing countries and can lead to open heart surgery as well as other serious complications such as stroke, or death.


OBJECTIVES: This study investigates the clinical characteristics, outcomes, and predictors of adverse events in patients diagnosed with IE at Chaophya Abhaibhubejhr Hospital.


METHODS: We conducted a prospective cohort study among patients who underwent echocardiography from October 1, 2017, to November 30, 2022, and were diagnosed with infective endocarditis. Demographic and clinical data, such as signs, symptoms, complications, laboratory results, and treatment, were collected and summarized. Risk factors for inpatient mortality and embolic phenomenon were determined by logistic regression analysis.


RESULTS: Of the 8,098 patients who underwent transthoracic echocardiography, 65 patients (0.8%) with infective endocarditis were identified. Forty-four were men (67.7%) with a median (Interquartile range (IQR) age of 51 years (41-62). A total of 26 (40%) had essential hypertension, 16 (24.6%) had chronic kidney disease, 8 (12.3%) received renal replacement therapy, and 13 (20%) had diabetes. Fever was present in 95.4% of cases, with a median (IQR) fever duration of 72 hours (48–336) before diagnosis. Heart failure was observed in 35 patients (53.5%), 14 (21.5%) needed an intensive care unit at presentation, and the median (IQR) APACHE II score was 11 (6-16). The majority were native valves (95.4%), and valve involvement comprised mitral valves (63.1%), aortic valves (27.7%), and tricuspid valves (9.2%), respectively. The Median (IQR) vegetation size was 9 millimeters (5-12), and the left ventricular ejection fraction was 64% (57-68%). Causative pathogens were Streptococcus spp. (40%) followed by Staphylococcus spp. (35.4%), and the median (IQR) time to positive hemoculture was 12 hours. Overall inpatient mortality was 12.3%. The common embolic phenomenon was ischemic stroke (23.1%), followed by meningitis (18.5%). By multivariate analysis, the associated factor for inpatient mortality was chronic renal failure (odds ratio 23.51, p=0.04), and the associated factor for stroke was the alteration of consciousness at presentation (odds ratio 17.67, p=0.004).


CONCLUSIONS: At the authors’ center, patients with infective endocarditis typically present with fever and congestive heart failure. The average age at diagnosis is 51 years, with the mitral valve being the most affected. The inpatient mortality rate is 12.3%, and 21.5% require ICU admission. Chronic renal failure is also a predictor of poor outcomes.


Thaiclinicaltrials.org number, TCTR20250216015

Article Details

Section
Original Article

References

Hoen B, Duval X. Infective endocarditis. N Engl J Med [Internet]. 2013 [cited 2024 May 27];369(8):785. Available from: https://www.nejm.org/doi/full/10.1056/NEJMc1307282

Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016;387:882-93.

Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol 2017;69:325-44.

Angsutararux T, Angkasekwinai N. Cumulative incidence and mortality of infective endocarditis in Siriraj hospital-Thailand: a 10-year retrospective study. BMC Infect Dis [Internet]. 2019 [cited 2024 May 27];19(1):1062. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6921523/pdf/12879_2019_Article_4689.pdf

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of Cardiology/American Heart Association task force on practice guidelines. Circulation [Internet]. 2014 [cited 2024 May 27];129(23):e521-643. Available from: https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000031

Li M, Kim JB, Sastry BKS, Chen M. Infective endocarditis. Lancet 2024;404:377-92.

Rouzet F, Iung B, Duval X. 18F-FDG PET/CT in infective endocarditis: new perspectives for improving patient management. J Am Coll Cardiol 2019;74:1041-3.

Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J 2023;44:3948-4042.

Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest 2007;132:1025-35.

Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. N Engl J Med 2017;377:713-22.

Kerdsin A. Human Streptococcus suis infections in Thailand: epidemiology, clinical features, genotypes, and susceptibility. Trop Med Infect Dis [Internet]. 2022 [cited 2024 May 27];7(11):359. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9695567/pdf/tropicalmed-07-00359.pdf

Wertheim HF, Nghia HD, Taylor W, Schultsz C. Streptococcus suis: an emerging human pathogen. Clin Infect Dis 2009;48:617-25.

Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL, et al. The 2023 duke-international society for cardiovascular infectious diseases criteria for infective endocarditis: updating the modified duke criteria. Clin Infect Dis 2023;77:518-26.

Kamde SP, Anjankar A. Pathogenesis, diagnosis, antimicrobial therapy, and management of infective endocarditis, and its complications. Cureus [Internet]. 2022 [cited 2024 May 27];14(9):e29182. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9572932/pdf/cureus-0014-00000029182.pdf

Gallacher PJ, McAllister DA, Mills NL, Cruden NL, Shah ASV, Dhaun N. Infective endocarditis hospitalizations and outcomes in patients with end-stage kidney disease: a nationwide data-linkage study. J Am Heart Assoc [Internet]. 2021 [cited 2024 May 27];10(19):e022002. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8649148/pdf/JAH3-10-e022002.pdf

Carneiro TS, Awtry E, Dobrilovic N, Fagan MA, Kimmel S, Weinstein ZM, et al. Neurological complications of endocarditis: a multidisciplinary review with focus on surgical decision making. Semin Neurol 2019;39:495-506.